✦ LIBER ✦

Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC)

✍ Scribed by CARLSON, J; REYES, C; OESTREICHER, N; LUBECK, D; RAMSEY, S; VEENSTRA, D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN134 Patient Preferences for Non-Small

✍ Bridges, J.F.; Mohamed, A.; Finnern, H.W.; Hauber, A.B.; Woehl, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

SEOM clinical guidelines for the treatme

✍ Camps, C.; Felip, E.; GarcÃa-Campelo, R.; Trigo, J. M.; Garrido, P. 📂 Article 📅 2013 🏛 Springer Milan 🌐 Spanish ⚖ 255 KB

Small cell lung cancer (SCLC) and non sm

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Combination of nedaplatin and vindesine

✍ Fujiwara, K; Takigawa, N; Segawa, Y; Eguchi, K; Shibayama, T; Kiura, K; Ueoka, H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

9057 POSTER Clinical Management and Trea

✍ Cruciani, G.; Vergnenégre, A.; Thomas, M.; Blasco-Colmenares, E.; Medina, J.; Ca 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

ESMO Minimum Clinical Recommendations fo

✍ Felip, E. 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 30 KB